Skip to content
MatchScript
Menu

Head-to-head · The Match Score

HealthRX vs JRNYS

Both scored on the same six-factor Match Score. HealthRX wins this matchup with a 86 to 68 edge.

Higher Match Score

HealthRX

#3 · Grade B+

Patients who want a verified, physician-supervised provider with an oral-tablet option and clear monthly pricing, and don't mind that some tiers are company-stated.

Visit HealthRX
VS

JRNYS

#149 · Grade C

People who want insured members wanting branded GLP-1s plus coaching at low medication cost.

Visit JRNYS

Factor by factor

The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.

Budget Fit
80
76
Speed to Start
86
60
Formulary Match
92
71
Support Level
86
82
Flexibility
84
55
Transparency
86
63

Price, coverage & formulary

DetailHealthRXJRNYS
Semaglutide$189/mo$89/mo (plus a separate fee, brand-name)
Tirzepatide$349/moNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualYesInjectable only
Match Score86 · B+68 · C
Winner: HealthRX

HealthRX edges out JRNYS, 86 to 68 on the default Match Score. A LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injectables — both molecules, transparent no-insurance pricing, and a brand-name path.

JRNYS is still a fair pick if its strengths line up with yours — best for: People who want insured members wanting branded GLP-1s plus coaching at low medication cost.

Worth a look either way: our overall #1 pick is CoreAge Rx (Match Score 91) — nationwide access, both molecules at one flat price, easy to cancel. Or take the 6-question quiz to see your personalized match.

Visit HealthRX Visit JRNYS

Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.

Full HealthRX reviewFull JRNYS review

More head-to-heads

Or browse alternatives to HealthRX and all comparisons.

Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.